Position in DGX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$13,710,956
+$668,268 QoQ
Shares Held
69,961
-6.9% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026DANSKE BANK A/S holds $320,359,923 across 16 Diagnostics & Research names. DGX ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
241,428 | $118,669,103 | |
| 2 | DHR |
Danaher Corp /De/
|
335,039 | $63,523,393 | |
| 3 | A |
Agilent Technologies, Inc.
|
248,991 | $28,379,993 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
44,067 | $24,760,806 | |
| 5 | DGX |
Quest Diagnostics Inc
This page
|
69,961 | $13,710,956 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
76,066 | $12,972,294 | |
| 7 | WAT |
Waters Corp /De/
|
41,749 | $12,432,852 | |
| 8 | NTRA |
Natera, Inc.
|
54,302 | $10,859,856 |
All Filings in DGX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,710,956 | 69,961 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $13,042,688 | 75,161 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $12,189,687 | 63,961 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $11,327,647 | 63,061 | Shares | Sole | 2025-12-18 | |
| 2025-03-31 | $9,975,862 | 58,959 | Shares | Sole | 2025-12-18 | |
| 2024-12-31 | $7,763,104 | 51,459 | Shares | Sole | 2026-03-18 | |
| 2024-09-30 | $8,951,869 | 57,661 | Shares | Sole | 2026-03-18 | |
| 2024-06-30 | $7,906,324 | 57,761 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $8,761,965 | 65,825 | Shares | Sole | 2026-03-18 | |
| No filing history on record for this holder in this stock. | ||||||